The assignments for the resonances in the 1Hand 13C NMRspectra of mithramycin in aqueous solution have been determined by a combination of 2D NMRmethods. Specific NOESY contacts observed between different moieties indicate that the drug assumes a compact conformation in aqueous solution. Fluorescence measurements are consistent with a compact structure for mithramycin in water and confirm the preference of mithramycin for binding to dG-containing nucleic acids. These studies provide a basis for the further physico-chemical characterization of mithramycin-DNA complexes.
The assignments for the resonances in the 1Hand 13C NMRspectra of mithramycin in aqueous solution have been determined by a combination of 2D NMRmethods. Specific NOESY contacts observed between different moieties indicate that the drug assumes a compact conformation in aqueous solution. Fluorescence measurements are consistent with a compact structure for mithramycin in water and confirm the preference of mithramycin for binding to dG-containing nucleic acids. These studies provide a basis for the further physico-chemical characterization of mithramycin-DNA complexes.
Mithramycin, produced by several Streptomyces strains, is an antitumor antibiotic which is a member of the aureolic acid family (for a general review of aureolic acid drugs, see ref 1) . It is characterized by a polyaromatic aglycone to whichare attached a hydrophilic side chain and two oligosaccharide side chains, one containing two sugars and the other three sugars (Fig. 1 ). Mithramycin differs from other members of the aureolic acid group, e.g., chromomycins and olivomycins, primarily in the identity of the sugar residues as well as of substituents on the sugars1*. An additional difference in some derivatives in the absence of the 7-methyl group on the aglycone (olivomycins). These antibiotics form complexes with DNA and, in the presence of Mg2+, serve as potent inhibitors of DNA-directed RNAsynthesis1~8). We have shown that mithramycin prevents protein binding to GC-rich regulatory regions of the SV409) and omyc1 0) promoters. These drugs have been shown to exhibit antitumor activity against a number of experimental tumors and are used clinically in the treatment of testicular tumors and of hypercalcemia and hypercalciuria THE JOURNAL OF ANTIBIOTICS DEC. 1990 associated with malignancies1à" 1 ià" 12).
Mithramycin has been characterized by XH and 13C NMRspectroscopy by Thiem and Meyer13) using acetone as the solvent. No NMRdata have been reported for this drug in the physiologically relevant solvent, water. By utilizing high resolution 2D NMRspectroscopic techniques at 600 MHz,we have made the XHand 1 3Cresonance assignments ofmithramycin in aqueous solution and characterized its free solution conformation. In addition, we have characterized some of the fluorescence properties of mithramycin which lend themselves for use in the study of mithramycin binding to DNA. NMRsamples in D2Owere prepared by dissolving l mg of mithramycin in 0.5ml of solvent. The sample also contained 0.10m sodium chloride and 0.01 m sodium phosphate buffer (mixed mono-and dibasic phosphates, total phosphate concentration = 0.01 m, pH 7.0).
Materials and Methods
All NMRexperiments were performed at an ambient probe temperature of 23°C on a Bruker AM-600 spectrometer operating at 600MHzfor protons. Quadrature detection was employed for all NMR experiments. 2D COSYexperiments were performed with a standard two-pulse sequence14). A spectral width of 6,600Hz was used with a 256 x 1,024 time domain data matrix and 1.5 seconds relaxation delay. For each of the tl values, 32 scans were accumulated. Phase-sensitive 2D NOESYspectra1 5) were obtained with mixing times of 200 and 500 mseconds using the same spectral width as in the 2D COSYexperiments, giving a 512 x2,048 hypercomplex data matrix. All 2D data processing was done on a micro VAXII computer utilizing the FT NMR software written by Dr. Dennis Hare (Hare Research, Inc., Woodinville, WA). The COSYdata were zero-filled to 1,024 x 2,048 and processed with a non-shifted sine bell squared window function in both tl and t2 dimensions. For 2D NOESYexperiments, data were zero-filled to 1,024 x 2,048 data points and multiplied by a 30-degree shifted sine bell squared window function in each dimension before Fourier transformation. The [1H-13C] correlation experiments were performed in the inverse detection mode16). Fluorescence measurements were made at ambient temperature (22~24°C) on a Perkin-Elmer MPF-3 spectrofluorometer. All solutions contained 0.01 m sodium phosphate buffer (pH 7.0) and 0.01 Msodium chloride. Concentrations of mithramycin were measured spectrophotometrically at 400 nmusing a calculated molar absorptivity of 10,000 M~Van.
Samples of calf thymus DNA, poly(dG-dC) and poly(dA-dT) were dialyzed successively against 0.0 1 m sodium phosphate buffer (pH 7.0) -1 m sodium chloride -0.05 m EDTA,several changes of distilled water and then the buffered saline using in these studies. Concentrations of calf thymus DNAand poly(dA-dT) were measured spectrophotometrically at 260 nm using molar absorptivities of 6,700 and 5,600 m~7cm, respectively16*; those of poly(dG-dC) were measured at 254nm using a molar absorptivity of 8,400 M-Vcm17).
Results and Discussion

NMRMeasurements
Chemical Shift Assignments Mithramycin A in Aqueous Solution: Mithramycin A has a fairly low solubility in pure D2O, but it will dissolve readily in aqueous buffered saline. Experiments were routinely performed in 0.01 Msodium phosphate buffer (pH 7.0) containing 0.10 m sodium chloride.
Figs. 2 and 3 show the 2D COSYand NOESYspectra, respectively, obtained at 600MHzof The COSYcross peak assignments for the anomeric protons are shown. The corresponding ID NMR spectrum is shown along the top. DEC. 1990 The complete assignments for the protons of mithramycin in D2Owere obtained from the 2D COSY and 2D NOESYdata. Specifically, 2D COSYwas employed to identify networks of /-coupled protons within each sugar and within the hydrophilic side chain. The 2DNOESY spectrum wasthen used to obtain sequence specific assignments for the different sugars and for the different protons in the aglycone. The anomeric protons for four of the five sugars were easily identified in the 2D COSYspectrum from their characteristic low field shift positions (S 5.49, 5.16, 4.86 and 4.58) , as well as from the pair of cross peaks exhibited by these protons because of connectivities to the 2-Heq and 2-Hax protons within each sugar. Identification of the remaining proton resonances for each sugar by following the /-connectivity networks was straightforward. In the case of sugar D, it was necessary to complement the COSYdata with the NOESY data to complete the proton assignments. The anomeric proton of this sugar exhibited an unusually large up field shift and resonates at 2.63 ppm. The origin of this upfleld shift is discussed later.
In the 2D NOESYspectrum, an aromatic proton (a singlet at 6.44ppm) showed NOESYcontacts to another singlet aromatic proton at 5.83ppmand to the anomeric proton at 5.16ppmfrom one of the sugars. Based on the NOESYcontacts predicted from the primary structure of the drug (Fig. 1) , the aromatic resonances at 6.44 and 5.83 ppm were assigned, respectively, to the 5-H and 10-H protons of the aglycone, while the anomeric proton was assigned to sugar A. Other interesting NOESY connectivities across interresidue linkages that were helpful in establishing specific assignments were: B-l-H to A-3-H; B-l-H to A-2-Heq; C-l-H to aglycone-2-H; D-l-H to C-3-H; E-l-H to D-3-H; and E-l-H to D-2-Hax. Some of these are shown in the 200 mseconds NOESYspectrum (Fig. 4) .
After completing the proton resonance assignments, the 13C resonances were assigned by 1H-13C COSYusing the inverse detection technique on the AM-600. This correlation spectrum (Fig. 5 ) clearly showed that a proton resonance resonating at 2.63ppm was attached to a 13C resonating at 102.6ppm, a value typical of an anomeric carbon involved in a glycosidic linkage. Conformational Features of Mithramycin in Water The 2D NOESY spectra exhibited a wealth of information that can be used to define the solution conformation of the drug in water. The anomeric proton resonance of sugar D is shifted to an unusually high field position at 2.63 ppm. The origin of this shift is the strong ring current interaction experienced by sugar D from the aromatic aglycone. Evidence for this suggestion is obtained from the NOESY contacts experienced by the 3-H, 4-H and 5-H protons of sugar D and by the 1-H, 5-H and 6-H protons of sugar E with the 5-H and 10-H protons of the aglycone (Figs. 3 and 4) . This observation, together with the large up field shift experienced by the 1-H of sugar D, suggests that the C-D-E trisaccharide moiety is folded over the aglycone in such a way that the 1-H proton of sugar D is exposed to a large ring current field from the aromatic group. Sugar E, on the other hand, is positioned in such a way that it does not experience a significant ring current shift, but is close enough to the 5-H and 10-H protons of the aglycone to experience NOESYcontacts. Wehave also observed weak NOESYcontacts between the 1-H of sugar A and the 4-H of sugar D. Thus, the A-B disaccharide unit is oriented in such a way as to bring sugar A closer to sugar D.
A weak NOESYcontact between T-H and 5'-CH3 of the hydrophilic side chain suggests that it folds back slightly, bringing the methyl group closer to the aglycone.
These data suggest that the conformational manifold of mithramycin in aqueous solution contains somewell-defined folded conformations. The hydrophobic nature of the molecule appears to result in a stacking interaction between the aglycone and the "aliphatic" side of sugar D, minimizing water access to the aromatic ring and enhancing solvation of the hydroxyl groups of sugar D.
These results pose an interesting contrast to chromomycin A3which exists in an extended conformation in methanol, a relatively polar solvent, and assumes a folded structure in dichloromethane, a fairly non-polar solvent18). Mithramycin in organic solvent (acetone) is found to assume an extended structure13), whereas our present studies show the drug is folded in aqueous solution. The differences presumably reside in the fact that chromomycin A3 has three of its sugar hydroxyls blocked (one with a methyl group and two with acetyl groups).
Fluorescence Measurements
Fluorescence excitation and emission spectra of mithramycinwere obtained in the samebuffer used in the NMRexperiments. Typical excitation and emission spectra are shown in Fig. 6 . The free drug exhibited several excitation maxima, including major peaks at 285 and 400nm, with a shoulder at about 245nm. The emission spectrum shows a very broad peak with the maximumat about 525nm. These maxima are to slightly lower wavelength than those reported in the literature19 '20) and probably reflect the lower ionic strength (approximately 0.01 m) and higher pH (pH 8) used in those studies. As reported by others20), the fluorescence emission of mithramycin is quenched by the presence of Mg2+, indicating interaction of the metal ion with the fluorophore. The Mg2+ -induced quenching ofmithramycin is markedly slower in the buffered saline than in a buffer comprised of0.01 m Tris-HCl (pH 7.2) or 0.01 m Tris-HCl -0.10 m sodium chloride, indicating a competition between phosphate and mithramycin for the metal ion.
In the presence of excess calf thymus DNAand Mg2+, the excitation peaks below 300 nm disappear as expected due to absorption of light by the DNAitself and the excitation peak at 400nm is reduced in intensity.
Addition of calf thymus DNAto mithramycin solutions containing Mg2+results in a slow increase of mithramycin fluorescence, however, the final fluorescence intensity is less than that of the corresponding mithramycin solution in the absence of Mg2+. This suggests that in the presence of DNAthere may be a redistribution of metal ion from a position in which the chromophore is affected (e.g., the aromatic hydroxyls) to another site (either on the mithramycin molecule or on the DNA). Similar results have been reported by others20). Metal ions are reported to bind to a unique site in complexes of the related chromomycin A3 to DNA21).
Hill19) reported that mithramycin fluorescence increased linearly with DNAconcentrations and suggested this as a basis for quantitating DNAin cells; however, it is likely, on the basis of our results and those of Cons and Fox20) , that that observed DNA-mediatedincrease in the fluorescence of mithramycin was the result of the "unquenching" by DNAof Mg2+-quenched mithramycin fluorescence. Quenching of mithramycin fluorescence was observed with both calf thymus DNAand poly(dG-dC); however, little change was seen with poly(dA-dT). These data are consistent with the knownspecificity of mithramycin for G-C sites in DNA1>22). Scatchard plots23) indicated the presence of two classes of binding sites for both calf thymus DNAand poly(dG-dC) (Fig. 7) . For calf thymus DNA, the higher affinity site showed an apparent Ka of about 2 x 105 M~l with an average stoichiometry of 1 site/40~50 base pairs; the lower affinity site has a Ka of about 6 x 103m-1 with a stoichiometry of about 1 site/9 base pairs. The binding constants are estimates based on straight-line extrapolations of the linear portions of the Scatchard plots. This treatment may be used when the dissociation constants differ by about two orders of magnitude or more24'25). Multiple sites might only be observable by fluorescence since no mention is made of multiple classes in previous UV-visible spectral measurements.
The binding constants obtained for mithramycin binding to poly(dG-dC) are similar to those found with DNA,with Ka values of about 2 x 105M"1and 5 x 103m"1 for the two classes of sites; however, the Scatchard plot is displaced to the right and shows roughly double the binding sites per base pair, as would be expected in going from a DNAwhich is about half G-Cto one which is completely G-C. The smaller number of mithramycin binding sites observed in our studies compared to those found by Cons and Fox20) mayreflect the higher ionic strength used in our studies. The use of changes in the UV-visible spectrum of mithramycin and related compounds to monitor its interactions with DNAhas long been known22'26'27). Although mithramycin fluorescence has been suggested as a means of quantitating DNAisolated from cells19), its utility in quantitating the interaction of the drug with DNAis fairly new and was reported20) as these studies were in progress. These data show that it will be possible to study the interaction ofmithramycin with various DNA's using fluorescence techniques. The findings that the spectral changes take time to attain equilibrium indicate that it mayalso be possible to monitor the kinetics of complexation between drug and DNA(and possibly metal ion). The irreversible loss of fluorescence peaks (both excitation and emission) upon prolonged exposure of mithramycin solutions in the fluorometer shows the great sensitivity of mithramycin to light and the need to take care in the measurement (and interpretation) of fluorescence data.
The net decrease in mithramycin fluorescence upon binding to DNAindicates that the fluorophore is going from a comparatively hydrophobic environment to one whichis moreaccessible to solvent since solvent would be expected to quench fluorescence in these molecules. The NMRexperiments indicate that mithramycin exists in a folded structure in water so that it is likely this folding contributes to the fluorescent character of the molecule. This suggests that the interaction of mithramycin with DNAaffects this intramolecular interaction in such a way that a decrease in fluorescence is observed. Studies by others21'28~30) on the interaction of the related chromomycinA3 with DNAoligomers show that the side chains of the molecule are indeed extended away from the chromophore in such complexes.
The fluorescence data are in agreement with a modeof mithramycin binding to DNAin which the fluorophore is more exposed to solvent in the complex than it is in free solution. This suggests that intercalation is an unlikely modeof binding since intercalation might be expected to lead to an increase in drug fluorescence. Once again, studies with the related chromomycin A3 indicate that the drug is a groove-binder21'28~30).
Conclusions NMR measurements have been made at 600MHzon mithramycin in aqueous solution. The conformational manifold of mithramycin in water exhibits some well-defined conformations in which the trisaccharide moiety is folded over the aglycone. Further, sugar A experiences spatial proximity to sugar D. The hydrophilic side chain appears to loop back on itself so that the end of the chain is near the chromophore. The molecule assumes something of a micellar structure, minimizing exposure of its hydrophobic areas to solvent and increasing exposure of its hydrophilic group.
Fluorometric measurementsare consistent with the existence of the mithramycin fluorophore in a fairly hydrophobic environment such as that which might result from the intramolecular stacking observed by NMR.Measurements in the presence of DNAshow that mithramycin has a preference for G-C containing DNA's and are consistent with the assumption by mithramycin of an extended conformation upon binding to DNA.
